We use cookies, including third-party cookies from Google to serve personalized ads through AdSense, to operate this site and understand how it is used. By continuing to browse, you accept this use. See our Privacy Policy and Terms of Use for details, including how to opt out of personalized advertising.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: Advocacy Group Helped Fund New FDA-Approved Orphan Drug
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > News > Advocacy Group Helped Fund New FDA-Approved Orphan Drug
News

Advocacy Group Helped Fund New FDA-Approved Orphan Drug

Wendy White
Wendy White
Share
2 Min Read
Nancy and Natalie Stack
SHARE

Nancy and Natalie StackI like to say rare diseases are different. One key way is that, for orphan conditions, it’s often the patients who are driving and funding the research.

Nancy and Natalie StackI like to say rare diseases are different. One key way is that, for orphan conditions, it’s often the patients who are driving and funding the research. A great example of this was highlighted in yesterday’s New York Times.

Natalie Stack has nephropathic cystinosis which, if left untreated, slowly destroys the organs in the body including the kidneys, liver, eyes, muscles and the brain. Thus it’s fatal by the first decade of life. Nephropathic cystinosis is estimated to impact 2,000 patients worldwide, including 500 in the U.S. and 800 in Europe.

Activated by a rare disease diagnosis
Similar to many other rare disease caregivers, Natalie’s parents, Nancy and Geoffrey, took action and started the Cystinosis Research Foundation. Their mission is “to support bench and clinical research that is focused on developing improved treatments and a cure for cystinosis.” The organization funded the research that led to Raptor Pharmaceutical Corporation’s approval yesterday of the therapy Procysbi. This story echoes others, including the evolution of the cystic fibrosis drug Kalydeco.

More Read

Emergency Supply Donor Group (ESDG) Responds To LA Hospital PPE Shortages
How Your Genes Will Drive Personalized Medicine
Future Med This Week
Track This Bill – Extending the Dependent Care Credit
Video:Telemedicine on the Frontier

The article also mentions the increasing numbers of orphan drugs, which is a wonderful advancement, but it is putting an increased financial burden on insurance companies and governments. To learn more, read Doug Paul’s informative article, Is Rare Disease Pricing Sustainable?

Do you have any rare disease stories like this to share?

TAGGED:orphan drugsrare diseases
Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5KFollowersLike
4.5KFollowersFollow
2.8KFollowersPin
136KSubscribersSubscribe

Latest News

Flat editorial illustration: Health-editorial illustration of the two-way relationship between substance use and disrupted sleep,
How Sleep Disruption Feeds the Addiction Cycle and What You Can Do About It
Addiction Recovery Mental Health Wellness
November 6, 2026
Flat editorial illustration: The article connects routine visual inspection and accurate barrier fit with protection of peristoma
Peristomal Skin Care: Healthy Skin, Irritation Causes, and When to See a WOC Nurse
Health Nursing
November 2, 2026
Flat editorial illustration: Clinical-trial operations editorial illustration combining healthcare and technology: country-specif
Clinical Study Operations Across Eastern European Research Markets
Health
October 31, 2026
Flat editorial illustration: A health-editorial scene of a first pain-management visit, bringing together attentive consultation,
What to Expect at Your First Pain Management Appointment
Therapies Wellness
October 29, 2026

You Might also Like

Study Finds Nursing Homes Have Inadequate Care and Discharge Planning

March 3, 2013

Patient Safety Toolkits from AHRQ

January 31, 2012

FDA Power Grab

May 31, 2012

CMS Announces Meaningful Use Final Rules & Stage 3 Implementation

October 22, 2015
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2026 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?